| Literature DB >> 30327779 |
Su-Han Chang1, Chiao-Hsuan Hsieh1, Yi-Ming Weng2, Ming-Shun Hsieh3,4,5, Zhong Ning Leonard Goh6, Hsien-Yi Chen1,7, Tung Chang1, Chip-Jin Ng1,7, Joanna Chen-Yeen Seak8, Chen-Ken Seak8, Chen-June Seak1,5,7.
Abstract
BACKGROUND: Renal abscess is a relatively uncommon yet debilitating and potentially fatal disease. There is no clearly defined, objective risk stratification tool available for emergency physicians' and surgeons' use in the emergency department (ED) to quickly determine the appropriate management strategy for these patients, despite early intervention having a beneficial impact on survival outcomes.Entities:
Mesh:
Year: 2018 PMID: 30327779 PMCID: PMC6169207 DOI: 10.1155/2018/6983568
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Rapid Acute Physiology Score (RAPS) scoring system.
|
| |||||
|---|---|---|---|---|---|
|
| 0 | +1 | +2 | +3 | +4 |
|
| 70–109 | 55–69 | 40–54 | ≤39 | |
| 110–139 | 140–179 | ≥180 | |||
|
| 70–109 | 50–69 | 130–159 | ≤49 | |
| 110–129 | ≥160 | ||||
|
| 12–24 | 10–11 | 6–9 | 35–49 | ≤5 |
| 25–34 | ≥50 | ||||
|
| ≥14 | 11–13 | 8–10 | 5–7 | ≤4 |
PR, pulse rate; MAP, mean arterial pressure; RR, respiratory rate; GCS, Glasgow Coma Scale.
Rapid Emergency Medicine Score (REMS) scoring system.
|
| |||||||
|---|---|---|---|---|---|---|---|
|
| 0 | +1 | +2 | +3 | +4 | +5 | +6 |
|
| <45 | 45–54 | 55–64 | 65–74 | >74 | ||
|
| 70–109 | 55–69 | 40–54 | ≤39 | |||
|
| 70–109 | 50–69 | 130–159 | ≤49 | |||
|
| 12–24 | 10–11 | 6–9 | 35–49 | ≤5 | ||
|
| 14 or 15 | 11–13 | 8–10 | 5–7 | 3 or 4 | ||
|
| >89 | 86–89 | 75–85 | <75 |
PR, pulse rate; MAP, mean arterial pressure; RR, respiratory rate; GCS, Glasgow Coma Scale; SpO2, peripheral oxygen saturation.
Modified Early Warning Score (MEWS) scoring system.
|
| ||||
|---|---|---|---|---|
|
| 0 | +1 | +2 | +3 |
|
| 101–199 | 81–100 | 71–80 | <70 |
|
| 51–100 | 41–50 | ≤40 | ≥130 |
|
| 9–14 | 15–20 | <9 | ≥30 |
|
| 35–38.4 | <35 | ||
|
|
| Reacts to | Reacts to |
|
Mortality in Emergency Department Sepsis (MEDS) scoring system.
|
|
|
|---|---|
|
| 6 |
|
| 3 |
|
| 3 |
|
| 3 |
|
| 3 |
|
| 3 |
|
| 2 |
|
| 2 |
|
| 2 |
1Defined as disease condition with >50% likelihood of predicted fatality within 30 days or metastatic cancer. 2Defined as respiratory rate > 20 breaths/min or requiring oxygen by mask or SpO2 < 90%. 3Defined as any difference from the patient's baseline in any of the three spheres of orientation or in their level of alertness.
Comparison of the characteristics of survivors and nonsurvivors.
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| No. | 152 | 144 | 8 | |
| Age (years), Median (IQR) | 54 (41-65) | 54 (41-64) | 67 (52-78.5) | 0.082 |
| Male, No. (%) | 48 (31.58) | 43 (29.86) | 5 (62.5) | 0.11 |
| Terminal illness, No. (%) | 3 (1.97) | 0 (0.00) | 3 (37.5) | <.001 |
| Nursing home resident, No. (%) | 2 (1.32) | 2 (1.39) | 0 (0) | 1.000 |
| Lower respiratory tract infection, No. (%) | 2 (1.32) | 1 (0.69) | 1 (12.5) | 0.103 |
| Body temperature (°C), Median (IQR) | 38.5 (37.55-39.45) | 38.5 (37.6-39.45) | 38.15 (36.15-39.35) | 0.455 |
| Pulse rate (/min), Median (IQR) | 114 (102-127.5) | 114 (101-125) | 143.5 (115-156.5) | 0.007 |
| Respiratory rate (/min), Median (IQR) | 20 (18-22) | 20 (18-21) | 27.5 (22.5-35) | 0.001 |
| Tachypnea or hypoxia, No. (%) | 34 (22.37) | 28 (19.44) | 6 (75) | 0.002 |
| SpO2 (%), Median (IQR) | 100 (95-100) | 100 (96-100) | 82.9 (65.65-92) | <.001 |
| Mean arterial pressure (mmHg), Median (IQR) | 75.33 (69-85) | 76.67 (69.83-85.5) | 65.67 (55-76.5) | 0.021 |
| Glasgow Coma Scale, No. (%) | 0.034 | |||
| ≦8 | 2 (1.32) | 1 (0.69) | 1 (12.5) | |
| 9~11 | 7 (4.61) | 6 (4.17) | 1 (12.5) | |
| ≧12 | 143 (94.08) | 137 (95.14) | 6 (75) | |
| Altered mental status, No. (%) | 19 (12.5) | 14 (9.72) | 5 (62.5) | <.001 |
| AVPU score, No. (%) | 0.003 | |||
| A | 137 (90.13) | 133 (92.36) | 4 (50) | |
| V | 6 (3.95) | 4 (2.78) | 2 (25) | |
| P | 7 (4.61) | 6 (4.17) | 1 (12.5) | |
| U | 2 (1.32) | 1 (0.69) | 1 (12.5) | |
| Leukocyte count (/ | 15.35 (11.3-20) | 15.25 (11.3-19) | 22.35 (6.4-27.05) | 0.426 |
| Platelets (×103/ | 222.5 (158-307) | 223.5 (163-312.5) | 153.5 (19-228.5) | 0.081 |
| Bandemia (Band>5%), No. (%) | 33 (21.71) | 28 (19.44) | 5 (62.5) | 0.013 |
| eGFR, No. (%) | <.001 | |||
| >50 | 118 (77.63) | 117 (81.25) | 1 (12.5) | |
| 10-50 | 32 (21.05) | 26 (18.06) | 6 (75) | |
| <10 | 2 (1.32) | 1 (0.69) | 1 (12.5) | |
| Septic shock, No. (%) | 19 (12.5) | 14 (9.72) | 5 (62.5) | <.001 |
| Treatment, No. (%) | 0.482 | |||
| Antibiotics only | 86 (56.58) | 82 (56.94) | 4 (50) | |
| Percutaneous drainage | 58 (38.16) | 54 (37.5) | 4 (50) | |
| Surgical drainage | 6 (3.95) | 5 (3.47) | 1 (12.5) | |
| Nephrectomy | 4 (2.63) | 4 (2.78) | 0 (0.00) | |
| Numbers of abscess, No. (%) | 0.178 | |||
| Solitary | 123 (80.92) | 118 (81.94) | 5 (62.5) | |
| Multiple | 29 (19.08) | 26 (18.06) | 3 (37.5) | |
| Scoring system, Median (IQR) | ||||
| MEDS | 3 (0-6) | 3 (0-5) | 11.5 (9-14.5) | <.001 |
| REMS | 5 (2-6.5) | 4.5 (2-6) | 9 (6-12.5) | 0.001 |
| RAPS | 2 (0-4) | 2 (0-4) | 5.5 (4-7.5) | 0.003 |
| MEWS | 4 (3-6) | 4 (3-6) | 8 (5.5-9) | 0.007 |
∗ indicates a statistically significant difference between survivors and nonsurvivors.
Results of univariate logistic regression analysis for MEDS, MEWS, RAPS, and REMS with respect to probability of death.
|
| OR (95% CI) | p-value |
|---|---|---|
| MEDS score | 1.571 (1.249-1.977) | 0.0001 |
| MEWS score | 1.529 (1.150-2.034) | 0.0035 |
| RAPS score | 1.619 (1.220-2.149) | 0.0009 |
| REMS score | 1.528 (1.189-1.962) | 0.0009 |
∗ indicates a statistically significant difference between survivors and nonsurvivors.
Figure 1Receiver operating characteristic curves for predicting death according the RAPS, MEWS, REMS, and MEDS scoring systems.
Sensitivities, specificities, and accuracy rates of RAPS, MEWS, REMS, and MEDS for predicting mortality.
|
| Accuracy rate | Optimal cut-off | Sen | Sp | PPV | NPV |
|---|---|---|---|---|---|---|
| MEDS | 88.82% | 9 | 87.50% | 88.89% | 30.43% | 99.22% |
| REMS | 66.45% | 6 | 87.50% | 65.28% | 12.28% | 98.95% |
| RAPS | 73.03% | 4 | 87.50% | 72.22% | 14.89% | 99.05% |
| MEWS | 91.45% | 8 | 62.50% | 93.06% | 33.33% | 97.81% |